Skip to Content

Sodium Nitroprusside Injection

Last Updated: October 11, 2017
Status: Current

Sodium Nitroprusside Injection

Products Affected - Description
  • All presentations are currently available

Reason for the Shortage
    • Akorn has sodium nitroprusside 25 mg/mL 2 mL vials available.
    • Exela launched Nipride RTU 0.5 mg/mL 100 mL vials in March 2017.
    • Nexus has sodium nitroprusside 25 mg/mL 2 mL vials available.
    • Sagent has sodium nitroprusside 25 mg/mL 2 mL vials available.
    • Valeant has Nitropress available.
Available Products
  • Nipride RTU injection, Exela Pharma Sciences
    0.5 mg/mL, 100 mL ready-to-use vial, 1 count (NDC 51754-1006-01)

 
Nitropress injection, Valeant
25 mg/mL, 2 mL vial, 1 count (NDC 00187-4302-02)
 
Sodium Nitroprusside injection, Akorn
25 mg/mL, 2 mL vial, 1 count (NDC 17478-0014-02)
 
Sodium Nitroprusside injection, Nexus Pharmaceuticals
25 mg/mL, 2 mL vial, 1 count (NDC 14789-0012-02)
 
Sodium Nitroprusside injection, Sagent
25 mg/mL, 2 mL vial, 1 count (NDC 25021-0310-02)

Estimated Resupply Dates

  • All presentations are available.

Updated

October 11, August 29, July 10, June 12, April 11, February 13, 2017; December 16, November 8, June 2, March 11, 2016; December 30, 2015, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide